Say your answer out loud first, then jot down the key points you made. Writing it helps you spot gaps — and it's what the AI feedback reads.
0 words
Applying natural selection to a clinical problem and understanding the behavioural and system-level responses.
A structure to build your own answer on — not a script.
Mechanism
Random mutations; selection pressure from antibiotics kills susceptible bacteria; resistant ones survive and multiply; horizontal gene transfer (plasmids) spreads resistance.
Drivers
Overprescribing (e.g. viral infections), incomplete courses debate, agricultural use, poor infection control, global travel.
Consequences
Routine infections and surgery become riskier.
Solutions
Stewardship, diagnostics, infection prevention, vaccination, agriculture regulation, incentives for new drug development.
A strong but not perfect answer. Read the notes to see why it works — then make your own version with your experiences.
Antibiotic resistance is evolution by natural selection happening fast enough1 for us to watch.
In any large population of bacteria, random mutations mean a few may happen to survive a particular antibiotic — perhaps they have an enzyme that breaks it down or a pump that removes it. When we use the antibiotic, it kills the susceptible bacteria and leaves the resistant ones with less competition, so they multiply. Bacteria can also share resistance genes directly with each other on plasmids2, which means resistance can spread between different species.
Anything that increases the use of antibiotics increases this selection pressure: prescribing them for viral infections where they don't help, using them heavily in farming, and poor infection control in hospitals allowing resistant bacteria to spread.
It matters because modern medicine depends on antibiotics — not just for infections but to make surgery, chemotherapy and caesarean sections safe.
Solutions work at several levels: prescribers using antibiotics only when needed and choosing narrow-spectrum drugs — known as stewardship; better rapid tests so we know when they're needed; infection prevention like hand hygiene and vaccination, which reduces infections in the first place; and regulating agricultural use. New antibiotics are also needed, but they're commercially unattractive because we'd want to use them as little as possible3, so governments are experimenting with different ways to pay for them.
Real interviews are won and lost here. Answer each one aloud.